SG11201702076WA - Cancer evaluation method and cancer evaluation system - Google Patents

Cancer evaluation method and cancer evaluation system

Info

Publication number
SG11201702076WA
SG11201702076WA SG11201702076WA SG11201702076WA SG11201702076WA SG 11201702076W A SG11201702076W A SG 11201702076WA SG 11201702076W A SG11201702076W A SG 11201702076WA SG 11201702076W A SG11201702076W A SG 11201702076WA SG 11201702076W A SG11201702076W A SG 11201702076WA
Authority
SG
Singapore
Prior art keywords
cancer evaluation
evaluation method
cancer
evaluation system
evaluation
Prior art date
Application number
SG11201702076WA
Inventor
Seiichi Inagaki
Naoyuki Okamoto
Original Assignee
Renatech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renatech Co Ltd filed Critical Renatech Co Ltd
Publication of SG11201702076WA publication Critical patent/SG11201702076WA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
SG11201702076WA 2014-09-15 2015-03-10 Cancer evaluation method and cancer evaluation system SG11201702076WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014187170 2014-09-15
PCT/JP2015/057005 WO2016042805A1 (en) 2014-09-15 2015-03-10 Cancer evaluation method and cancer evaluation system

Publications (1)

Publication Number Publication Date
SG11201702076WA true SG11201702076WA (en) 2017-06-29

Family

ID=55532854

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702076WA SG11201702076WA (en) 2014-09-15 2015-03-10 Cancer evaluation method and cancer evaluation system

Country Status (6)

Country Link
US (1) US10845372B2 (en)
EP (1) EP3182132B1 (en)
JP (1) JP6082478B2 (en)
KR (1) KR102305151B1 (en)
SG (1) SG11201702076WA (en)
WO (1) WO2016042805A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6629782B2 (en) * 2017-04-04 2020-01-15 株式会社レナテック Age-related macular degeneration risk assessment method and system
JP6946133B2 (en) * 2017-09-27 2021-10-06 株式会社レナテック Cancer risk assessment method and cancer risk assessment system
JP6875451B2 (en) * 2018-09-26 2021-05-26 株式会社レナテック Dog cancer risk assessment method and cancer risk assessment system
WO2020067261A1 (en) * 2018-09-26 2020-04-02 株式会社レナテック Cancer risk evaluation method and cancer risk evaluation system for dogs
JP7412279B2 (en) * 2020-06-03 2024-01-12 株式会社日立ハイテク Image diagnosis method, image diagnosis support device, and computer system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821786B2 (en) 2002-04-25 2004-11-23 Future Data Inc. Diagnostic test for elemental imbalances
EP2081027A4 (en) 2006-08-04 2009-09-23 Ajinomoto Kk Method for evaluation of lung cancer, lung cancer evaluation apparatus, lung cancer evaluation method, lung cancer evaluation system, lung cancer evaluation program, and recording medium
JP2011047715A (en) 2009-08-25 2011-03-10 La Belle Vie Kk Method for detecting cancer based on comprehensive analysis of mineral components in hair

Also Published As

Publication number Publication date
JPWO2016042805A1 (en) 2017-04-27
EP3182132B1 (en) 2019-01-02
WO2016042805A1 (en) 2016-03-24
EP3182132A1 (en) 2017-06-21
KR20170054384A (en) 2017-05-17
EP3182132A4 (en) 2017-10-25
US10845372B2 (en) 2020-11-24
US20170254821A1 (en) 2017-09-07
JP6082478B2 (en) 2017-02-15
KR102305151B1 (en) 2021-09-27

Similar Documents

Publication Publication Date Title
HK1248285A1 (en) Method and system for determining cancer status
GB201617433D0 (en) Evaluation system and method
SG11201609892RA (en) Transport-container system and method
SG10201405182WA (en) Method and system
SG11201606077TA (en) Transaction system and method
GB201407711D0 (en) Communnication system and related method
HUE040180T2 (en) Quick-charging method and system
PL3357000T3 (en) Cancer detection systems and methods
GB201421814D0 (en) System and method
SG11201703335QA (en) Transaction system and method
SG11201606186WA (en) Remittance system and method
GB201417272D0 (en) Measurement method and system
SG11201702076WA (en) Cancer evaluation method and cancer evaluation system
GB201506496D0 (en) Measurement system and methods
GB201616609D0 (en) Spectroscopy method and system
SG10201403334XA (en) Detection system and method
GB201523060D0 (en) Speed-limit-compliance system and method
IL257514A (en) Cancer detection method
GB201415688D0 (en) Method and Systems
GB201404184D0 (en) Method and system
GB2553212B (en) Measurement systems and methods
GB2526808B (en) Door system and method
GB201417539D0 (en) Measurement system and methods
SG11201606778TA (en) Methods and systems for quantification without standard curves
GB201417309D0 (en) Sensing methods and systems